ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) is defined as the negative immunohistochemical test results of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (Her-2) [2,3].